Select the financial statements you wish to view below. The reports below may be viewed on either an annual or quarterly basis.
- Income Statement
- Quarterly
All numbers in thousands USD
Period Ending | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
Total Revenue | 64,727,000 | 61,858,000 | 62,020,000 | 56,517,000 |
Cost of Revenue | 19,684,000 | 18,505,000 | 19,623,000 | 16,302,000 |
Gross Profit | 45,043,000 | 43,353,000 | 42,397,000 | 40,215,000 |
Operating Expenses | ||||
Research Development | 8,056,000 | 7,653,000 | 7,142,000 | 6,659,000 |
Selling General and Administrative | 9,062,000 | 8,119,000 | 8,223,000 | 6,661,000 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 0 | 0 | 0 |
Total Operating Expenses | 17,118,000 | 15,772,000 | 15,365,000 | 13,320,000 |
Operating Income or Loss | 27,925,000 | 27,581,000 | 27,032,000 | 26,895,000 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | 675,000 | 854,000 | 506,000 | (389,000) |
Earnings Before Interest And Taxes | 27,951,000 | 27,527,000 | 27,435,000 | 27,809,000 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | 27,250,000 | 26,727,000 | 26,526,000 | 27,284,000 |
Income Tax Expense | 5,214,000 | 4,788,000 | 4,656,000 | 4,993,000 |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | 22,036,000 | 21,939,000 | 21,870,000 | 22,291,000 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | 22,036,000 | 21,939,000 | 21,870,000 | 22,291,000 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 22,036,000 | 21,939,000 | 21,870,000 | 22,291,000 |